Ionis Pharmaceuticals Files 8-K
Ticker: IONS · Form: 8-K · Filed: Apr 30, 2025 · CIK: 874015
Sentiment: neutral
Topics: sec-filing, 8-k, financial-reporting
TL;DR
IONIS filed an 8-K on 4/30/25 for operations/financials. No new info here.
AI Summary
Ionis Pharmaceuticals, Inc. filed an 8-K on April 30, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a standard reporting event.
Why It Matters
This filing serves as a public record of Ionis Pharmaceuticals' operational and financial status, providing transparency to investors and stakeholders.
Risk Assessment
Risk Level: low — This is a routine SEC filing for reporting operational and financial information, not indicating any new or unusual risks.
Key Players & Entities
- IONIS PHARMACEUTICALS, INC. (company) — Registrant
- April 30, 2025 (date) — Date of report
- 2855 Gazelle Court Carlsbad, CA 92010 (address) — Principal Executive Offices
- ISIS PHARMACEUTICALS INC (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Ionis Pharmaceuticals, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed as of April 30, 2025.
What is the principal executive office address for Ionis Pharmaceuticals, Inc.?
The principal executive office address for Ionis Pharmaceuticals, Inc. is 2855 Gazelle Court, Carlsbad, CA 92010.
What was the former name of Ionis Pharmaceuticals, Inc.?
The former name of Ionis Pharmaceuticals, Inc. was ISIS PHARMACEUTICALS INC.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2025 regarding IONIS PHARMACEUTICALS INC (IONS).